Filana Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Austin, TX
FLNA chart
What traders are saying about $FLNA
Latest postsFilana Therapeutics, Inc. news
- Filana Therapeutics, Inc. (FLNA) Seasonal returns chart
Yahoo Finance UK ·
- Filana Therapeutics, Inc. (SAVAW) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Filana Therapeutics Q3 Results: Loss per share narrows to $(0.22)
scanx.trade ·
- Filana Therapeutics Reports Q3 Net Loss of $10.7 Million, $47 Million in Cash
TradingView ·
- Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Seizures affect 80% to 90% of people with a rare disorder. Filana expects screening for an epilepsy study by early 2027.
Stock Titan ·
- Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
Yahoo Finance ·
- Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
Yahoo Finance ·
- Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
Yahoo Finance ·
- Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Data I/O And 2 Other Promising Penny Stocks To Watch
Yahoo Finance ·
- Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
Yahoo Finance ·
Filana Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$91.0M | -$24.3M | -$97.2M | -$76.2M |
| Diluted EPS | $-1.88 | $-1.46 | $-2.32 | $-1.90 |
| Total assets (year end) | $118.4M | $157.5M | $151.7M | $234.8M |
| Cash and equivalents (year end) | $95.5M | $128.6M | $121.1M | $201.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Filana Therapeutics, Inc.
- Ticker
- FLNA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Austin, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1069530
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
Frequently asked questions
What exchange is Filana Therapeutics, Inc. listed on?
Filana Therapeutics, Inc. trades on the Nasdaq under the ticker symbol FLNA.
What industry is Filana Therapeutics, Inc. in?
Filana Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Filana Therapeutics, Inc. headquartered?
Filana Therapeutics, Inc.'s business address on file with the SEC is in Austin, TX.
When does Filana Therapeutics, Inc.'s fiscal year end?
Filana Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Filana Therapeutics, Inc. report?
Filana Therapeutics, Inc. reported $41.1M in revenue for calendar year 2013, according to its SEC filings.